93421 ⎘
Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups; Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
CYCLOPENTANE COMPOUND
#2NOVEL POTASSIUM CHANNEL INHIBITORS
#3ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#4CYCLOHEXYL BETA-HYDROXY ALKYL AMINES AND MEDICAL USES THEREOF
#5NOVEL POTASSIUM CHANNEL INHIBITORS
#6ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C-17
#7INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY
#8HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#9Cyclic diones as herbicidal compounds
#10Potassium channel inhibitors
#11Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#12Inhibitors of the WNT/beta-catenin pathway
#13Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
#14Process for the preparation of indanones
#15Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#16HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#17Process for hydrogenating ketones in the presence of Ru(II) catalysts
#18Farnesoid X receptor agonists and uses thereof
#19SHIP1 modulators and methods related thereto
#20Antioxidant Inflamation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#21HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#22HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#23SHIP1 modulators and methods related thereto
#24Sulfonic acid derivative compounds as photoacid generators in resist applications
#25Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#26SHIP1 MODULATORS AND METHODS RELATED THERETO
#27Substituted 4-aminocyclohexane derivatives
#28Inhibitors of Memapsin 2 Cleavage for the Treatment of Alzheimer's Disease
#29Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#30Sulfonamide derivative and use thereof
#31Cycloalkyl guanidine FF-ATPase inhibitors and therapeutic uses thereof
#32Substituted 4-aminocyclohexane derivatives
#33Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#34ORGANIC COMPOUNDS
#35Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
#36Adamantanamine derivative
#37Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-17
#38Substituted 4-aminocyclohexane derivatives
#39Indane derivatives
#40Proteasome inhibitors having chymotrypsin-like activity
#41Process for hydrogenating ketones in the presence of Ru(II) catalysts
#42N-hydroxy-benzamids for the treatment of cancer
#43PROCESS FOR THE PREPARATION OF SULFOMATE-CARBOXYLATE DERIVATIVES
#44Histone deacetylase inhibitors, process for preparation and uses thereof
#45Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
#46PROCESS FOR PRODUCTION OF COMPOUND HAVING ANTAGONISTIC ACTIVITY ON NPYY5 RECEPTOR, AND USEFUL CRYSTAL
#47NPY Y5 ANTAGONIST
#48NPY Y5 antagonist
#49Amine derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
#50Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#51Amine derivative having NPY Y5 receptor antagonistic activity
#52Azetidine Derivatives as GlyT1 Inhibitors
#53METHOD FOR PRODUCING SALT OF 4-SULFINYLAMINO-1-CYCLOHEXANECARBOXYLIC ACID
#54Amine derivative having NPY Y5 receptor antagonistic activity
#55Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
#56Hydrazine amide derivative
#57SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#58Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
#59SOLUBLE EPOXIDE HYDROLASE INHIBITORS
#60Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
#61Process for the preparation of sulfomate-carboxylate derivatives
#62Substituted Hydroxyethylamines
#63N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
#64Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
#65Sulfonamide compound
#66Compounds which potentiate glutamate receptor and uses thereof in medicine
#67NPY Y5 antagonist
#68Preventives/remedies for urinary disturbance
#69Preventives/remedies for urinary disturbance
#70Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
#71Process for producing trans-4-amino-1-cyclohexanecarboxilic acid derivative
#72Preventives/remedies for urinary disturbance
#732,3-Oxidosqualene-lanosterol cyclase inhibitors
#74Substituted urea neuropeptide Y Y5 receptor antagonists